Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
Log in EVIDENCE Une revue Cochrane 1 rsume deux essais cliniques randomiss (ECR) 2,3 : Dans la premire tude 2 , 38 patients externes ont t randomiss pour recevoir 2 000 mcg de vitamine B12 par jour par voie orale ou 1 000 mcg de vitamine B12 par voie intramusculaire les 1 er , 3 e , 7 e , 10 e , 14 e , 21 e , 30 e , 60 e et 90 e jours
Studies using BPC-157 and separate L-arginine do not prove the properties of an arginate salt
doi: 10.1038/s41390-020-01106-w
It is well established that glutathione taken orally does not increase glutathione inside our cells
Your surgeon will provide specific guidelines on when you can gradually resume more demanding activities
